Exit Review Area  Objective Understand Your Role in the Exit Review Area Understand Your Role in the Exit Review Area.

Slides:



Advertisements
Similar presentations
Smallpox Vaccination for Response Teams The Decision is Yours! of and.
Advertisements

Hospital Issues and Smallpox Vaccine Lisa G. Kaplowitz, M.D., M.S.H.A. Deputy Commissioner Emergency Preparedness and Response Virginia Department of Health.
Understanding Novel H1n1 Influenza The mission of the Houston Department of Health & Human Services is to work in partnership with the community.
Smallpox: Risks of Vaccination Patricia Lee MD.
DMC HVSH Guidelines for Suspected Smallpox Vaccine Adverse Events Evaluation Confirm that individual is smallpox vaccinee (should have PVN card) Those.
Impetigo 13/04/2017 Impetigo Clinical knowledge summaries:- Impetigo has unpleasant connotations to many. In the past.
SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Quek Boon Har UMMC.
Influenza A, H1N1 “Swine Flu” The Facts and How to Protect Yourself.
DIAGNOSIS OF SWINE FLU FFFFor diagnosis of swine influenza a infection, respiratory specimen would generally need to be collected within the first.
Influenza Annual Training Health, healing and hope.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
INFLUENZA (FLU) Management Presentation
H1N1 / Swine Flu Dr. Steve Shelton H1N1 Medical Director Palmetto Health Dr. Steve Shelton H1N1 Medical Director Palmetto Health.
Get the Facts About Novel H1N1 Influenza
H1N1.
Influenza Prevention We anticipate that there will be two types of influenza illness and two different types of influenza vaccine this year Seasonal influenza.
Management of Smallpox Vaccine Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.
Site Care. Site Care Education Goals Review normal reactions after vaccination Provide site care instructions (oral and written) Provide contact information.
Smallpox Physician and Clinician Seminar January 6, 2003 North Dakota Department of Health.
Understanding Novel Flu H1N1 Formerly “Swine Flu”
Swine Flu Guidelines & Recommendations for Preventing Influenza Spread in ChildrenBy Gehan A Alsawah, MD Lecturer of Pediatrics, Pediatric Cardiology.
Back to the Future? Pre-Event Smallpox Vaccination John R. Lumpkin, MD, MPH, FACEP Illinois Department of Public Health.
MRSA Methicillin Resistant Staphylococcus Aureus
U. S. Centers for Disease Control and Prevention
Influenza Annual Training
By: Sharee Windish, Haley Bradley & Jordan North
Natalie Garcia Anatomy&Physiology 4 th Period. History Of The Disease  First described in 1860 by Ferdinand von Hebra as a severe, self-limiting disorder.
Erythema By Dr. Mohamad Nasr Lecturer Of Dermatology & Venereology.
Meningitis Created By: VSU Student Health Center Nursing Staff.
ESRD Network 6 5 Diamond Patient Safety Program
Flu Shot Myth Busters Fact: Seasonal influenza vaccination is the most important way to prevent seasonal influenza virus infections
SIGNS AND SYMPTOMS: Fever Cough Sore throat Body aches Chills & fatigue Diarrhea & vomiting.
Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:
Smallpox Vaccine J. Michael Lane, MD, MPH January 2003.
Chickenpox (varicella)
Streptococcus The Throat Pathogen.
Presented by Dr. Lisa Rotz, BPRP, CDC.
Soft Tissue Infections
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.
Seasonal and H1N1 Flu Guidance on helping Child Care and Early Childhood Programs respond to Influenza Season September 17, 2009 Presented by: Leona Davis.
Smallpox By Amber, Jacob, And Olivia. Smallpox is a serious and contagious disease that causes a rash on the skin.
H1N1 VIRUS SWINE FLU. What is the H1N1 Virus? It is a new virus that is spread from person to person first detected in people in the United States in.
3-Oct-15CHS / BHEL Hospital1 WELCOME. How to Combat Swine Flu 3-Oct-152CHS / BHEL Hospital.
Bacterial Meningitis By Dana Burkart.
38 th National Immunization Conference May 14, 2004 Smallpox Vaccine Adverse Events Revisited. What have we learned? John Neff MD Seattle,Washington.
Smallpox Vaccination Mark Upfal, MD, MPH Detroit Medical Center Emergency Medicine Grand Rounds Detroit Receiving Hospital February 13, 2003 Collaborators:
DoD Smallpox Vaccination Program Science – Quality – Confidence – Care 3 June 2003 COL John D. Grabenstein, RPh, PhD Military Vaccine (MILVAX) Agency U.S.
Service Member Receives Vaccine NO REACTION LOCAL REACTION (Occur more often in women than men) Document. Educate. Continue to screen for exclusion criteria.
Smallpox Vaccine Administration  Learning Objectives Demonstrate appropriate vaccine administration techniques Demonstrate appropriate vaccine administration.
Pandemic Influenza Awareness H1N Comstock.com CDC Comstock.com.
By: Makayla Claiborne and Amber Howard SMALLPOX. What is Smallpox? Smallpox also called variola is defined as an acute infectious disease, meaning that.
Smallpox Vaccine Adverse Events Public Health Guidance for Clinicians A Teaching Set Reviewing Key Points in the MMWR Report.
Chicken Pox.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Hand Foot and Mouth Disease Dr. Carla Hoo. Hand Foot Mouth Disease Hand, foot, and mouth disease (HFMD) is a common viral illness of infants and children.
Chapter 5 Wound Care. Copyright © 2007 Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Pressure Ulcers Serious complication of immobility –Implement a.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Influenza A, H1N1 “Swine Flu”
Job Description of Non-Medical Vaccinator Assistant
PHARMACOTHERAPY III PHCY 510
Module 7 Communicating about CD-JEV vaccine with caregivers
                       What is a Rash?.
Smallpox.
Smallpox Vaccine Contraindications and Screening
Smallpox Vaccinee Evaluation and Follow-Up
Meningitis Created By: VSU Student Health Center Nursing Staff
Presentation transcript:

Exit Review Area  Objective Understand Your Role in the Exit Review Area Understand Your Role in the Exit Review Area

Job Description of Exit Review Area Personnel (Majority of Counseling Will Be Showing Where in Patient’s Package) Knowledge of All Materials in the Patient’s Package (May need to read information to the patient) Knowledge of All Materials in the Patient’s Package (May need to read information to the patient) Knowledge of & Ability to Answer Any Questions on: Knowledge of & Ability to Answer Any Questions on: Contraindications of Vaccine Contraindications of Vaccine Normal Side Effects Normal Side Effects Care of Vaccine Site Care of Vaccine Site “Take” “Take” Adverse Events Adverse Events # to call for Questions # to call for Questions How to Deal With an Immediate Emergency

Supplies For Exit Review Area  Table & Chairs  CDC Smallpox Vaccination Pamphlet  Extra Forms of: CDC/VIS on Vaccination Site Appearance And Care CDC/VIS on Vaccination Site Appearance And Care CDC/VIS on Reaction After Vaccination CDC/VIS on Reaction After Vaccination  May Need Ammonia, 2x2 Gauze, Tape

Vaccine “Takes”, Normal Vaccine Side Effects, and Site Care  Job Description: Exit Review Personnel Knowledge of all materials in the Patient’s information package Knowledge of all materials in the Patient’s information package Knowledge of/ability to answer any questions on: Knowledge of/ability to answer any questions on: Contraindications of vaccineContraindications of vaccine Normal Side EffectsNormal Side Effects Care of Vaccine SiteCare of Vaccine Site “Take”“Take” Adverse EventsAdverse Events How to deal with an immediate emergency How to deal with an immediate emergency

Clinical Response to Vaccination* Symptom/sign Papule Pustule Maximum erythema Scab Scab separation Time after Vacc 2-5 days 7-10 days 8-10 days 14 days 21 days * typical response in a nonimmune person

Normal Response To Smallpox Vaccination First dose Booster dose Day 0Day 3Day 7Day 10Day 14 First Dose Booster Dose Day 0Day 3Day 7Day 10Day 14

Progression of smallpox vaccination site in a non-immune person

TAKE VERSUS NON-TAKE  Major reaction and take: area of definite induration/congestion surrounding a central pustule about day 7 – 8 indicates a take.  Equivocal – Erythema and a small, temporary papule that resolves quickly. Revaccination is required.  No reaction at all. Revaccination is required.

 Virus can be recovered at site from time of papule until scab separates  Site should be covered until scab falls off (approximately 3 weeks)  Site should be kept dry  Normal bathing can occur if covered by waterproof bandage Vaccination Site Care

 Hand hygiene immediately after handling dressing or contact with site CRITICAL to preventing spread  Clothing over site (long sleeves when sleeping)  May place gauze with tape over vaccine site, allowing site to “breathe”

Site Care at Home  Change dressing if gauze becomes saturated (wet, soiled, or loose)  If drainage gets on clothes or linens, wash in hot water (160°) separately  If bandage removed/changed at home, place in ziploc bag and discard in regular trash (also scabs)  Avoid placing ointments or ice on vaccination site

Normal Side Effects of Smallpox Vaccine  Pain, swelling, erythema at vaccination site (40 -47% have pain)  Regional lymphadenopathy (21-38%) Begins 3-10 days after vaccination Begins 3-10 days after vaccination Can persist for 2-4 weeks after vaccination site heals Can persist for 2-4 weeks after vaccination site heals

Reaction Rates among adults  Elevated temperature 7 to 12 days post vaccination: 17% >100 o F 17% >100 o F 1.4% >102 o F 1.4% >102 o F  Systemic symptoms (malaise, myalgias) 8 – 10 days post vaccination  % sufficiently ill to miss work, school, or recreational activities or had trouble sleeping

Normal Variants of Vaccine Reaction  Local edema at vaccination site  Lymphangitis  Regional lymphadenopathy (nonfluctuant)  Satellite lesions (Incidence of 2.4 – 6.6%)

Lymphangitis following smallpox vaccination

Satellite lesions

Local Reactions Following Smallpox Vaccine  Allergic reactions to bandage and tape adhesives  Large primary vaccination reactions (“robust primary takes” – RPT)  Secondary bacterial infection

Allergic reaction to tape

Local Reactions to Adhesive  Erythema corresponds to placement of adhesive tape  No systemic symptoms  Treat with antihistamines, NSAIDs, frequent bandage/tape change  Steroid treatment not recommended

Robust Primary Takes (RPT)  Expected variant of normal reaction  >3 inches of erythema with induration, pain, warmth  Occur in 5%-15% of recipients  Peak at day 8-10 post-vaccination  May resemble bacterial infection (“viral cellulitis”)

Robust primary take

Robust Primary Takes (RPT)  Observe carefully  Supportive therapy Rest affected limb Rest affected limb Analgesia (non-aspirin) Analgesia (non-aspirin) NSAIDs NSAIDs  Usually improve in h

Secondary bacterial infection of vaccination site

Secondary Bacterial Infection  More common among children than adults  Usually Staphylococcus aureus or Group A beta hemolytic Streptococci  Anaerobic and mixed infections may occur  Evaluate with gram stain and culture  Antibiotic therapy based on culture

Rashes Following Smallpox Vaccine (Erythema multiforme, roseola vaccinia, toxic erythema, postvaccinial urticaria)  Flat, erythematous, macular, or urticarial lesions  Usually do not become vesicular  Do not appear to involve viral multiplication or systemic dissemination of vaccinia virus  Occur approximately 10 days after vaccination  Resolve spontaneously within 2 to 4 days

Erythema multiforme following smallpox vaccination

Inadvertent Inoculation  Transfer of vaccinia virus from vaccination site to another site on the body, or to a close contact  Most frequent complication of smallpox vaccination (about ½ of all complications)  Occurred cases per million primary vaccinations  Most common sites are face, eyelid, nose, mouth, genitalia, rectum  Lesions contain vaccinia virus

Inadvertent Inoculation  Uncomplicated lesions require no therapy, self-limited, resolve in ~3 weeks  VIG may speed recovery if extensive or painful genital involvement  Hand washing after contact with vaccination site or contaminated material most effective prevention

Inadvertent inoculation

 Adverse reaction rates may be higher today than in 1960s  More persons at risk because of higher prevalence of immunosuppression and eczema/atopic dermatitis  Adverse reaction rates lower among previously vaccinated persons Smallpox Vaccine: Significant Adverse Reactions

Smallpox Vaccine Adverse Reactions, and Rates* Reaction Primary Vaccination Inadvertent inoculation Generalized vaccinia Eczema vaccinatum Progressive vaccinia (vaccinia necrosum) Post-vaccinial encephalitis 3-12 Death1 * Rates per million primary vaccinations

Generalized Vaccinia  Vesicles or pustules appearing on normal skin distant from the vaccination site  Rash distribution is indiscriminate – follows no set pattern  Often accompanied by fever, headache, and myalgias  Occurred cases per million primary vaccinations  Usually occur 6-9 days after vaccination

Generalized vaccinia

Generalized Vaccinia  Generally self-limited  Most cases do not require therapy  VIG may be considered for recurrent disease or severe disease  Lesions contain vaccinia

Post-vaccinial Encephalitis  Usually affects primary vaccinees <12 months of age and adolescents and adults receiving a primary vaccination  Presents with any of a variety of CNS signs (e.g., ataxia, confusion, paralysis, seizures, or coma)  15%-25% die  25% develop neurological sequelae  Occurred 3-12 cases per million primary vaccinations (rare)

When to seek Medical Care  Inadvertent inoculation  Widespread rash  Ongoing infection of the skin at the vaccination site with tissue destruction  Allergic response to vaccine (hives, resp difficulty, etc)  Persistent headache,, confusion, seizures, or other neurologic symptoms

How to Handle Emergencies in Exit Review Area *Nauseated, anxious, dizzy - Have patient to sit or lie down - Stay with the patient - Have other staff member get float nurse or EMS personnel *Immediate rash, shortness of breath, wheezing - Have patient to lie down - Stay with the patient - Have other staff member get EMS personnel immediately